Back to search
FDAFDA · Food and drugs·Recall number D-840-2013

MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30

Published August 14, 2013 · Recall initiated: June 21, 2013

Summary

FDA records drug Class II recall D-840-2013, published August 14, 2013 and initiated June 21, 2013. Recalling firm: AstraZeneca Pharmaceuticals LP; Status: Terminated; Reported quantity: 81,900 total vials; Lot: NDC 0310-321-30, lot JX109, expiration 2/2015; lot JY042, expiration 2/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Precipitate; potential for incomplete constitution upon addition of diluent.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AstraZeneca Pharmaceuticals LP
Distributor
USA and Puerto Rico
Lot
NDC 0310-321-30, lot JX109, expiration 2/2015; lot JY042, expiration 2/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30 recalled?

Yes. FDA published recall D-840-2013 on August 14, 2013. Reported hazard: Presence of Precipitate; potential for incomplete constitution upon addition of diluent.

What should I do if I have this product?

Voluntary: Firm initiated · Letter